|
Abu-El-Haija, Aya
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Adams, April
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Ali, Muhammad
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Amlie-Wolf, Louise
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Ayers, Kara
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Bachir, Suha
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Barnett, Claudia
|
Program Committee Member/Staff
|
No Relevant Financial Relationships
|
|
Barrios, Roia
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Bennett, Robin
|
Moderator
|
No Relevant Financial Relationships
|
|
Bent, Robyn
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Best, Hunter
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Bianchi, Diana
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Bird, Lynne
|
Moderator
|
No Relevant Financial Relationships
|
|
Birsoy, Ozge
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Bivona, Stephanie
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Bowling, Kevin
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Boyce, Alison
|
CE Presenter
|
Research funding: Amgen; Ultragenyx; Kyowa Kirin
|
|
Brand, Harrison
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Brothers, Kyle
|
CE Presenter
|
Research funding: Invitae
|
|
Burns, Kaitlyn
|
CE Presenter
|
Consultant: Illumina; Has ended
|
|
Callahan, Katherine
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Cao, Yang
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Carey, John
|
Moderator
|
Chair Safety Committee: Merck; Has ended
|
|
Cassini, Thomas
|
Moderator
|
No Relevant Financial Relationships
|
|
Chakraborty, Pranesh
|
CE Presenter
|
Research funding: Biomarin; Novartis; Takeda; Cambrooke; Vitaflo; Nutricia
Research funding: Biogen; Has ended
Advisory Board: Novartis; Sanofi; Ultragenyx; Waters; Horizon; Has ended
|
|
Chandra, Bharatendu
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Chapman, Kimberly
|
CE Presenter
|
Consultant: Hemoshear Therapeutics
|
|
Chen, Wei-Liang
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Chitayat, David
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Cho, Mildred
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Chung, Brian Hon-Yin
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Chung, Wendy
|
Platform Presenter
|
Board of Directors: Prime Medicine; Rallybio
|
|
Cohen, Jenna
|
Program Committee Member/ Staff
|
No Relevant Financial Relationships
|
|
Conboy, Erin
|
Program Committee Member/ Liaison
|
Consultant: Lamar Health
|
|
Cone, Kelsey
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Conway, Laura
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Corona, Rosario
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Coughlin, Curtis
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Culver, Julie
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Dahlroth, Jane
|
Program Committee Member/ Staff
|
No Relevant Financial Relationships
|
|
Danos, Arpad
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Dawood, Moez
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Dauber, Andrew
|
Platform Presenter
|
Consultant: Novo Nordisk; Pfizer; Bridge Bio/QED
Research funding: Pfizer
Consultant: with Tyra; Has ended
|
|
Deignan, Josh
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Del Gobbo, Giulia
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Dempsey, Melissa
|
Moderator
|
Employee: Illumina
|
|
Dickson, Alexa
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Diekema, Douglas
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Dinulos, Mary Beth
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Dipple, Katrina
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Drivas, Theodore
|
Platform Presenter
|
Consultant: Ono Pharmaceutical; Has ended
|
|
Dubuc, Adrian
|
CE Presenter
|
Consultant relationship Abbvie; Has ended
|
|
Duque Lasio, Maria Laura
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Duyzend, Michael
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Eddleman, Keith
|
Program Committee Member/ Liaison/ Moderator
|
Speaker’s Bureau: Mead Johnson Nutrition
|
|
Ehrenfeld, Jesse
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Eldomery, Mohammad
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Ellinwood, N. Matthew
|
Moderator
|
Representative of patient advocacy: Denali Therapeutics; Regenxbio, Inc.; Takeda; BioMarin
|
|
Elliott, Alison
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Elsea, Sarah
|
Moderator
|
Research funding: PTC Therapeutics; Speragen, Inc
|
|
Ewing, Altovise
|
CE Presenter
|
Employee: Roche Genentech
|
|
Farrow, Emily
|
Platform Presenter
|
Speaker's Bureau: Kyowa Kirin; Has ended
|
|
Fernandez, Jessica
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Fieg, Elizabeth
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Fisher, Deborah
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Fortini, Barbara
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Freire, Penelope
|
Program Committee Member/ Staff
|
No Relevant Financial Relationships
|
|
Gambello, Michael
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Ghazani, Arezou
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Gibson, Jane
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Giordano, Jessica
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Glass, Ian
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Gold, Nina
|
Moderator/CE Presenter
|
Consultant: RCG Consulting, LLC
Speaker’s Bureau: Ambyr Genetics
|
|
Gold, Jessica
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Goldstein, Jennifer
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Gracia, Clarisa
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Gorzynski, John
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Gray, Shannon
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Gray, Kathryn
|
CE Presenter
|
Scientific Medical Advisor: BillionToOne
Consultant: Aetion; Roche; Has ended
|
|
Griffith, Obi
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Groopman, Emily
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Gropman, Andrea
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Gu, Shen
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Guha, Saurav
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Guzman, Herodes
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Haldeman-Englert, Chad
|
Moderator/CE Presenter
|
Consultant: Illumina
|
|
Hamadeh, Zeid
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Hamilton, Afifa
|
CE Presenter
|
Employee: eviCore Healthcare
|
|
Hand, Jennifer
|
CE Presenter
|
Section Editor: UpToDate, Inc
|
|
Harmatz, Paul
|
CE Presenter
|
Consultant: Aeglea; Audentes; Capsida; Chiesi; Edigene; Renoviron; Saliogen; Inventiva Pharma; Has ended
Consultant: Grace Science; Rallybio; Neurogene; Novel Pharma; Orchard Therapeutics
Research funding: Adrenas; Amicus; Ascendis; ASPA; Azafaros; BioMarin; Calcilytics; Denali; Homology; JCR Pharmaceuticals; Orphazyme; QED Therapeutics; RegenXbio; Sangamo; Takeda; Idorsia; Prevail; Allievex
|
|
Harr, Margaret
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Hisama, Fuki
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Hoffman, Jodi
|
Program Committee Member/ Liaison/ Moderator
|
No Relevant Financial Relationships
|
|
Holm, Ingrid
|
CE Presenter
|
Consultant: Biomarin
|
|
Hoover-Fong, Julie
|
CE Presenter
|
Consultant: Biomarin; QED Therapeutics
Scientific Medical Advisor: Biomarin; QED Therapeutics
Research funding: QED; Biomarin; Innoskel
|
|
Hopkin, Robert
|
CE Presenter
|
Consultant: Aro Biotherapeutics; Has ended
Honoraria: Amicus Therapeutics
Scientific Medical Advisor: Chiesi Farmaceutici; Denali Therapeutics; Sangamo Therapeutics; Sanofi; Acadia Pharmaceuticals
|
|
Hoppman, Nicole
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Huang, Yue
|
CE Presenter
|
Scientific Medical Advisor: Horizon Therapeutics
|
|
Hufnagel, Robert
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Hurst, Anna
|
Moderator
|
Consultant: CFD Research
|
|
Jarvik, Gail
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Jeng, Linda
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Ji, Yuan
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Jobanputra, Vaidehi
|
Platform Presenter
|
Consultant: Illumina; Has ended
|
|
Justice, Anne
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Kalantari, Forouh
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Kellis, Manolis
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Kelly, Melissa
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Kim, Jaeseung
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
King, Jennifer
|
Program Committee Member/ Liaison/ Moderator
|
Consultant: Sonio
|
|
Kingsmore, Stephen
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Klugman, Susan
|
Program Committee/ Board of Directors Liaison/ Moderator/ CE Presenter
|
No Relevant Financial Relationships
|
|
Knoppers, Bartha Maria
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Kobren, Shilpa
|
Moderator
|
No Relevant Financial Relationships
|
|
Kopp, Nathan
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Korson, Mark
|
CE Presenter
|
Research funding: Recordati
Consultant: HemoShear
Research: Aeglea; Travere; Has ended
Consultant: Glycomine; Eton; Acer; Tessera; Solace Nutrition; Has ended
Speaker's Bureau: Moderna; Has ended
|
|
Kozel, Beth
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Kritzer, Amy
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Krstic, Nevena
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Kulchak Rahm, Alanna
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Landrum, Melissa
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Larson, Austin
|
CE Presenter
|
Consultant: Illumina; Entrada Therapeutics; Has ended
Consultant: Travere; Stealth Biotherapeutics; Astellas; UCB Pharma; Tisento
|
|
Lee, Brendan
|
CE Presenter
|
Royalties: Sanofi; Pacira; GQ BIO Therapeutics; Acer Therapeutics
Consultant: Biomarin
|
|
Legare, Janet
|
CE Presenter
|
Speaker's Bureau: BioMarin; QED/Bridge Bio
|
|
Lemke, Amy
|
Program Committee Member/ Liaison/ Co-Moderator
|
No Relevant Financial Relationships
|
|
Leung, Marco
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Lewis, Robert
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Li, Hong
|
Moderator/CE Presenter
|
Consultant: Logicbio;Travere
Consultant: Homology; Moderna; Has ended;
Scientific Medical Advisor: Ultragenyx; Has ended;
Consultant: Acer Therapeutics; Has ended;
Research funding: Hemoshear
|
|
Li, Marilyn
|
CE Presenter
|
Consultant: Agilent Technologies; Bayer Pharmaceuticals; Has ended
|
|
Li, Dong
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Lianoglou, Billie
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Ligon, Azra
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Lin, Angela
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Liu, Shuxi
|
CE Presenter
|
Employee: GeneDx
|
|
Liu, Pengfei
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Lockwood, Christina
|
CE Presenter
|
Scientific Medical Advisor: LGC Group
|
|
Luperchio, Teresa
|
Co-Moderator
|
Stock: Invitae; Natera; Ionis Pharmaceuticals; Moderna; Nokia
|
|
Madjunkov, Mitko
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Malkin, David
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Manickavasagam Amudhavalli, Shivarajan
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Manolio, Teri
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Maxwell, Kara
|
CE Presenter
|
No Relevant Financial Relationships
|
|
McClure, Michelle
|
Co-Moderator
|
Stock: Abeona; Bionano
|
|
McDonald-McGinn, Donna
|
Moderator
|
Scientific Medical Advisor: Natera
|
|
McGowan, Michelle
|
CE Presenter
|
No Relevant Financial Relationships
|
|
McNeil, Shannon
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Meredith, Stephanie
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Micke, Kestutis
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Miller, Danny
|
CE Presenter
|
Stock: MyOme; Has ended
Research funding: Oxford Nanopore Technologies
|
|
Mintz, Kevin
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Morales Corado, Andres
|
Program Committee Member/ Therapeutics Liaison / Moderator/CE Presenter
|
Research funding: Phoenix Nest Inc.
|
|
Morava, Eva
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Mori, Mari
|
Moderator
|
No Relevant Financial Relationships
|
|
Morton, Cynthia
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Mosera, Mackenzie
|
Moderator
|
No Relevant Financial Relationships
|
|
Mosley, Jonathan
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Mueller, Daniel
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Muthusamy, Karthik
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Myers, Melanie
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Novotny, Edward 'Rusty'
|
CE Presenter
|
Advisory Board: UCB Pharmaceuticals
Scientific Medical Advisor: Jazz Pharmaceuticals
|
|
Null, Elizabeth
|
Moderator
|
No Relevant Financial Relationships
|
|
Offord, Stephanie
|
CE Presenter
|
Consultant: Illumina; Has ended
|
|
Omorodion, Jacklyn
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Paras, Andrea
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Parikh, Aditi
|
Program Committee Member/ Education Liaison/ Moderator
|
No Relevant Financial Relationships
|
|
Patterson, Wesley
|
CE Presenter
|
Consultant: Illumina, Inc.; Has ended
|
|
Peay, Holly
|
CE Presenter
|
Research funding: Sarepta Therapeutics; Travere Therapeutics; Janssen Pharmaceuticals; Orchard Therapeutics
|
|
Peck, Larissa
|
Platform Presenter
|
Speaker's Bureau: AstraZeneca; Merck; Invitae; Has ended
Consultant: AstraZeneca; Has ended
|
|
Pena, Loren
|
Moderator
|
Consultant: CVS Caremark; Cyclo Therapeutics Inc; Moderna
Research funding: Zevra Pharma
|
|
Pereira, Elaine
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Petry, Natasha
|
CE Presenter
|
Stock: Teva Pharmaceutical; Has ended
|
|
Phillips, John
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Pope, Kathleen
|
Moderator
|
No Relevant Financial Relationships
|
|
Posey, Jennifer
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Powell, Cynthia
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Powell, Sabrina
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Prakash Bharwani, Karishma
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Pritchard, Amanda
|
CE Presenter
|
Research funding: Applied Therapeutics; Moderna
|
|
Prows, Cynthia
|
Moderator
|
No Relevant Financial Relationships
|
|
Pruthi, Sandhya
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Punnoose, Ann
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Raca, Gordana
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Radford, Jane
|
Program Committee Member/ Staff
|
No Relevant Financial Relationships
|
|
Rana, Huma
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Reddi, Honey
|
CE Presenter
|
Consultant: Biofidelity Inc
|
|
Regier, Debra
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Rehder, Catherine
|
CE Presenter
|
Consultant: Amicus Theraputics; Alexion Pharmaceuticals; Has ended
Research funding: Amicus Therapeutics; Alexion Pharmaceuticals
|
|
Rehm, Heidi
|
CE Presenter
|
Research funding: Microsoft
|
|
Restrepo, Michael
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Rosenfeld, Jill
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Rowsey, Ross
|
Program Committee Member/ Liaison/ Modrerator/CE presenter
|
No Relevant Financial Relationships
|
|
Ruzhnikov, Maura
|
Moderator
|
No Relevant Financial Relationships
|
|
Sadle, Charles
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Saunders, Carol
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Savage, Sharon
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Schaaf, Christian
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Schelhaas, Andrea
|
Moderator
|
No Relevant Financial Relationships
|
|
Scheuner, Maren
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Schott, Clara
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Schuler, Bryce
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Seifert, Bryce
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Sethuraman, Meena
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Shaaban, Sherin
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Shashi, Vandana
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Shayota, Brian
|
CE Presenter
|
Scientific Medical Advisor: Travere Therapeutics; Horizon Therapeutics USA; Ultragenyx Pharmaceutical Inc; Has ended
|
|
Sheehan, Elizabeth
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Shelkowitz, Emily
|
Moderator
|
Research funding: Moderna; Ultragenyx; Sanofi
|
|
Shelley, John
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Shen, Wei
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Simard, Jacques
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Skaar, Todd
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Slavotinek, Anne
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Sobreira, Nara
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Somerville, Cherith
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Spears, Kathryn
|
Platform Presenter
|
Research funding: Cycle Pharmaceuticals
|
|
Stergachis, Andrew
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Stewart, Douglas
|
Moderator/CE Presenter
|
No Relevant Financial Relationships
|
|
Stramondo, Joseph
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Strande, Natasha
|
Moderator
|
No Relevant Financial Relationships
|
|
Suhrie, Kristen
|
CE Presenter
|
Speaker's Bureau: GeneDx; Has ended
|
|
Summar, Marshall
|
Moderator
|
No Relevant Financial Relationships
|
|
Talati, Asha
|
CE Presenter
|
Research funding: BillionToOne, Inc.
|
|
Tayeh, Marwan
|
Program Committee Member/ Liaison
|
No Relevant Financial Relationships
|
|
Thomas-Wilson, Amanda
|
Co-Moderator
|
No Relevant Financial Relationships
|
|
Thompson, Katarzyna
|
Program Committee Member/ Liaison/ Co-Moderator
|
No Relevant Financial Relationships
|
|
Tischkowitz, Marc
|
Program Committee Member/ Liaison/ Moderator
|
No Relevant Financial Relationships
|
|
Tolusso, Leandra
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Treat, Lauren
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Ungar, Wendy
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Valverde, Kathleen
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Van Driest, Sara
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Varela Luquetti, Daniela
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Vockley, Jerry
|
CE Presenter
|
Research funding: Ultragenyx; Kriya Therapeutics; Renee Pharmaceuticals
|
|
Vora, Neeta
|
CE Presenter
|
Grant support: Illumina; Has ended
|
|
Wallace, Byron
|
CE Presenter
|
Consultant relationship with Codametrix; Has not ended
|
|
Wang, Christiana
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Wapner, Ronald
|
CE Presenter
|
No Relevant Financial Relationship
|
|
Weis, Shawna
|
CE Presenter
|
Employee: Morphosys, Inc.; Has ended
|
|
Weitzel, Jeffrey
|
Moderator/CE Presenter
|
Speaker's Bureau: AstraZeneca
Consultant: Natera
|
|
Wells, Melanie
|
Program Committee Member/ ACMG CEO
|
No Relevant Financial Relationships
|
|
Wenger, Tara
|
CE Presenter
|
Research funding: GeneDx
|
|
West, Michael
|
CE Presenter
|
Consultant: Alexion; Amicus; Chiesi; Protalix; Idorsia; Sanofi
Research funding: Takeda
Speaker's Bureau: Amicus; Sumitomo; Sanofi; Takeda
Scientific Medical Advisor: Alexion; Alnylam; Amicus; Sanofi; Takeda
Royalties: AvroBio/University Health Network
|
|
Whelan, Colleen
|
Program Committee Member/ Staff
|
No Relevant Financial Relationships
|
|
Wheeler, Matthew
|
Platform Presenter
|
Research funding: Bristol Myers Squib; Cytokinetics; Salubris Biotherapeutics; Pfizer
|
|
Williams-Rogers, Cassia
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Wilson, William
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Wurth, Rachel
|
Platform Presenter
|
No Relevant Financial Relationships
|
|
Yasinskaya, Yuliya
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Zea Vera, Alonso
|
CE Presenter
|
No Relevant Financial Relationships
|
|
Zepeda Mendoza, Cinthya
|
Program Committee Member/ DEI Liaison/ CE Presenter
|
No Relevant Financial Relationships
|